Skip to main content

Kevin Donnelly

Executive Director, Toxicology & Pathology, Catalyze360

he/him/his

Eli Lilly and Company

Bio

Kevin Donnelly, DVM, PhD, DABT is a veterinary pathologist and toxicologist with almost 30 years experience in the field of human and animal pharmaceutical research and development. Kevin has working in large and small pharmaceutical research companies and also worked in contract research services industry. His experience includes comparative biomedicine of human and animal pathology, toxicology, pharmacology, and practice of laboratory animal medicine. Kevin is a member of the American Veterinary Medical Association (AVMA) with experience in education standards and accreditation for colleges of veterinary medicine around the world having served for 7 years, including Chair, on the AVMA Council on Education. Kevin is a frequent invited speaker at national and international meetings, conferences, summits, and for university lectures on a variety of topics regarding comparative biomedicine and how pharmacotherapy of human and animal disease are intertwined in raising standards of public health, animal health, and ensuring food security.